Abstract:Objective The aim of this study was to examine the clinical characteristics and metabolic features of subclinical Cushing’s syndrome (SCS), and to investigate the association of the cortisol level with the metabolic features in patients with SCS. Methods 52 patients with non-functioning adenoma (NFA), 45 patients diagnosed with SCS and 61 patients with overt adrenal Cushing’s syndrome (CS) participated in this study. Clinical data and endocrine function of the patients as well as histological findings were all reviewed. Results 1) The average age of patients with SCS was 52.56±13.25 years, 68.9% patients were female. No difference was detected in age, gender and BMI between patients with SCS and NFA (P > 0.05). Compared to patients with SCS, CS was more common in younger and female patients (43.90±13.83, 83.6%). The prevalence of diabetes mellitus, hypertension, and osteopenia/osteoporosis were significantly higher in patients with SCS compared to those with nonfunctioning tumors (57.8% vs 32.7%, 73.3% vs 53.8%, 41.2% vs 19.2%; P < 0.05). No difference was detected between SCS and CS patients in the prevalence of metabolic disease. 2) Compared to patients with NFA, plasma ACTH level is lower in patients with SCS (P < 0.05). Whereas, the midnight cortisol level and cortisol level after 1mg overnight dexamethasone suppression is higher in SCS than NFA (P < 0.05). No difference was detected between SCS and NFA in 24h urinary free cortisol and early-morning cortisol level (P > 0.05). Compared to SCS, the derangement of ACTH-cortisol axis is more prominent in CS patients demonstrated as suppressed plasma ACTH level and elevated plasma and 24h urine cortisol level. 3) In SCS cohort, SBP, FBG and HbA1c correlated positively with 24h urinary free cortisol (r =0.394, P =0.021; r =0.426, P =0.011, r =0.398, P =0.015; respectively). When controlling for age and gender, the correlation was also significant (P < 0.05). No correlations were found between BMI, TG, HDL and 24h urinary free cortisol. Conclusion Patients with SCS showed slight derangement of the circadian rhythm of cortisol and cortisol excess, and increased prevalence of metabolic disease. Furthermore, the cortisol level was related closely to blood glucose and blood pressure. Our findings might suggestive in therapeutic decision making (conservative vs surgery approach) in patients with SCS.

Left ventricular subclinical systolic myocardial dysfunction assessed by speckle-tracking in patients with Cushing's syndrome

Left Ventricular Subclinical Systolic Myocardial Dysfunction Assessed by Speckle-Tracking in Patients with Cushing’s Syndrome

Subclinical myocardial dysfunction in coronary slow flow phenomenon: identification by speckle tracking echocardiography.

Epicardial adipose tissue volume highly correlates with left ventricular diastolic dysfunction in endogenous Cushing's syndrome

Evaluation on subclinical left ventricular systolic dysfunction in patients with pre-diabetes by three-dimensional speckle tracking echocardiography

Assessment Of Left Ventricular Dysfunction By Using Speckle Tracking Imaging In Patients With Masked Hypertension

Estimation of Left Ventricular Myocardial Mechanics in Patients with Subclinical Hypothyroidism Using Three-Dimensional Speckle Tracking Echocardiography

Clinical assessment of cardiac impairment favored by two-dimensional speckle tracking echocardiology in patients with systemic sclerosis

Evaluation of Left Ventricular Systolic Function in Patients with Different Types of Ischemic Heart Disease by Two-Dimensional Speckle Tracking Imaging

A Novel Method for Sensitive Determination of Subclinical Left-Ventricular Systolic Dysfunction in Subjects with Obstructive Sleep Apnea

Cardiac Involvement Assessment in Systemic Sclerosis Using Speckle Tracking Echocardiography: a Systematic Review and Meta-Analysis

LEFT VENTRICULAR STRAIN IN PATIENTS WITH HYPERTENSIVE HEART DISEASE AND NORMAL EJECTION FRACTION ASSESSED BY SPECKLE TRACKING ECHOCARDIOGRAPHY

Evaluating left ventricular systolic function of patients with severe preeclampsia usingthree-dimensional speckle-tracking echocardiography

Assessment of Myocardial Function by Two-Dimensional Speckle Tracking Echocardiography in Patients with Kawasaki Disease: a Mid-Term Follow-Up Study.

SAT-370 Clinical Characteristics and Metabolic Features of Patients with Subclinical Cushing's Syndrome and Its Correlation with Cortisol Level

Global and Regional Myocardial Function Assessment in Symptomatic Patients with Chronic Coronary Syndrome Using Longitudinal Strain and Noninvasive Myocardial Work.

Speckle-Tracking Echocardiographic Layer-Specific Strain Analysis on Subclinical Left Ventricular Dysfunction in Patients with Primary Aldosteronism

Two-Dimensional Speckle Tracking Imaging in Assessment of Left Ventricular Systolic Function in Essential Hypertension with Normal Ventricular Geometry

Speckle tracking echocardiography can predict subclinical myocardial involvement in patients with sarcoidosis: A meta‐analysis

Use of speckle tracking echocardiography in evaluating cardiac dysfunction in patients with acromegaly: an update

Feasibility of assessing cardiac systolic function using longitudinal fractional shortening calculated by two-dimensional speckle tracking echocardiography.